Figure 4 | Scientific Reports

Figure 4

From: Evaluation of a developmental hierarchy for breast cancer cells to assess risk-based patient selection for targeted treatment

Figure 4

Co-expressions of TMEM98, GPR64 and FAT4 in the CD44+/CD24− BCC subset. BCCs, stably transfected with Oct4-GFP, were co-labeled with CD44-APC and CD24−PE and the population of CD44 + /CD24− (Top panels) further studied for the expression of TMEM98, GPR64 and FAT4 (middle panels). CD44+/CD24− populations were further stratified based on Oct4 expression (Oct4hi, Oct4med and Oct4low) and then studied for TMEM98, GPR64 and FAT4 (lower panels). The Δ Geometic (Geo) mean fluorescence intensity (MFI) for TMEM98, GPR64 and FAT4 are shown in each panel. The Geo mean was calculated as the change from the actual MFI – the MFI of the isotype.

Back to article page